Pfizer CFO Dave Denton departing Aug 15 for consumer goods role; Guegan named interim

Filed June 18, 2026 · Period ending June 18, 2026 · ~1 min read

Key Changes

• high

  CFO Dave Denton stepping down Aug 15, 2026 for consumer goods opportunity outside pharma; company states departure unrelated to financial results or disagreements on accounting/reporting policies.

  Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation verify on EDGAR →
• medium

  Cecile Guegan, 21-year Pfizer veteran and current SVP Finance for Global Biopharmaceutical Business, named Interim CFO effective Aug 16 while comprehensive internal/external search underway.

  Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation verify on EDGAR →
• medium

  CEO credits Denton with overseeing major acquisitions including Seagen, Biohaven, and Metsera, characterized as among most important recent transactions expected to benefit company long-term.

  Exhibit 99.1 view on EDGAR →